Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,080 | -5,060 | -3,620 | -2,560 | -1,030 |
| Depreciation Amortization | 60 | 250 | 180 | 110 | 50 |
| Other Working Capital | 420 | -190 | -130 | -20 | 40 |
| Other Operating Activity | 970 | 620 | 300 | 180 | -150 |
| Operating Cash Flow | $-630 | $-4,380 | $-3,270 | $-2,290 | $-1,090 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -4 | -4 | -4 | 0 |
| Other Investing Activity | -139 | -446 | -336 | -226 | -120 |
| Investing Cash Flow | $-140 | $-450 | $-340 | $-230 | $-120 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 90 | 3,220 | 3,210 | 470 | 450 |
| Financing Cash Flow | $90 | $3,220 | $3,210 | $470 | $450 |
| Beginning Cash Position | 2,000 | 3,610 | 3,610 | 3,610 | 3,610 |
| End Cash Position | 1,310 | 2,000 | 3,200 | 1,550 | 2,840 |
| Net Cash Flow | $-680 | $-1,600 | $-400 | $-2,050 | $-760 |
| Free Cash Flow | |||||
| Operating Cash Flow | -630 | -4,380 | -3,270 | -2,290 | -1,090 |
| Free Cash Flow | -630 | -4,380 | -3,270 | -2,290 | -1,090 |